| 2024-09-14 |
复牌提示：
2024-09-13 19:50:00 停牌，复牌日期 2024-09-17 00:00:01
|
| 2024-08-08 |
股东大会：
将于2024-09-04召开股东大会
会议内容 ▼▲
- 1.To consider and vote on a proposal (the “Merger Proposal”) to adopt the Merger Agreement and approve the Merger. A copy of the Merger Agreement is attached as Annex A to the accompanying proxy statement.
2.To consider and vote on a proposal (the “Adjournment Proposal”) to adjourn the Special Meeting, if necessary, and for a minimum period of time reasonable under the circumstances, to ensure that any necessary supplement or amendment to the proxy statement accompanying this notice is provided to Company stockholders a reasonable amount of time in advance of the Special Meeting, or to solicit additional proxies if there are insufficient votes at the time of the Special Meeting to approve the Merger Proposal.
3.To consider and vote on a proposal (the “Compensation Proposal”), to approve, by non-binding, advisory vote, the compensation that will or may be paid or become payable to our named executive officers that is based on or otherwise relates to the Merger.
|
| 2024-08-07 |
详情>>
股本变动：
变动后总股本5438.42万股
|
| 2024-08-07 |
详情>>
业绩披露：
2024年中报每股收益-0.18美元,归母净利润-956.2万美元,同比去年增长39.02%
|
| 2024-05-14 |
详情>>
业绩披露：
2024年一季报每股收益-0.12美元,归母净利润-625.1万美元,同比去年增长-25.47%
|
| 2024-05-14 |
财报披露：
美东时间 2024-05-14 盘前发布财报
|
| 2024-03-26 |
详情>>
内部人交易：
Ashman Philip股份减少12103.00股
|
| 2024-03-08 |
详情>>
业绩披露：
2023年年报每股收益-0.84美元,归母净利润-2139.1万美元,同比去年增长-18.14%
|
| 2023-11-02 |
详情>>
业绩披露：
2023年三季报(累计)每股收益-1.11美元,归母净利润-1761万美元,同比去年增长-22.91%
|
| 2023-08-11 |
详情>>
业绩披露：
2023年中报每股收益-2.07美元,归母净利润-1568万美元,同比去年增长-72.88%
|
| 2023-06-29 |
股东大会：
将于2023-08-01召开股东大会
会议内容 ▼▲
- 1.To elect three Class I directors (Proposal 1);
2.To ratify the appointment of Grant Thornton LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2023 (Proposal 2);
3.To approve, on an advisory basis, the compensation of our named executive officers (Proposal 3);
4.To approve, on an advisory basis, the frequency of future stockholder advisory votes on the compensation of our named executive officers (Proposal 4);
5.To approve the adoption of the Alimera Sciences, Inc. 2023 Equity Incentive Plan (the “2023 Plan”) (Proposal 5);
6.To approve the issuance of shares of our common stock upon conversion of our Series B Convertible Preferred Stock (the “Series B Preferred”), and the issuance of shares of common stock upon exercise of certain warrants (the “Warrants”) (Proposal 6);
7.To transact such other business as may properly come before the Annual Meeting or any adjournments or postponements thereof.
|
| 2023-05-15 |
详情>>
业绩披露：
2023年一季报每股收益-0.71美元,归母净利润-498.2万美元,同比去年增长16.34%
|
| 2023-03-31 |
详情>>
业绩披露：
2022年年报每股收益-2.59美元,归母净利润-1810.7万美元,同比去年增长-314.16%
|
| 2022-11-14 |
详情>>
业绩披露：
2022年三季报(累计)每股收益-2.05美元,归母净利润-1432.7万美元,同比去年增长-5286.09%
|
| 2022-08-05 |
详情>>
业绩披露：
2022年中报每股收益-1.3美元,归母净利润-907万美元,同比去年增长-331.55%
|
| 2022-06-01 |
股东大会：
将于2022-07-12召开股东大会
会议内容 ▼▲
- 1.To elect three Class III directors (Proposal 1);
2.To ratify the appointment of Grant Thornton LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2022 (Proposal 2);
3.To approve, on an advisory basis, the compensation of our named executive officers (Proposal 3);
4.To transact such other business as may properly come before the Annual Meeting or any adjournments or postponements thereof.
|
| 2022-05-12 |
详情>>
业绩披露：
2022年一季报每股收益-0.85美元,归母净利润-595.5万美元,同比去年增长-63.24%
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-04-30 |
股东大会：
将于2021-06-15召开股东大会
会议内容 ▼▲
- 1.To elect two Class II directors (Proposal 1);
2.To approve an amendment to the Company’s 2019 Omnibus Incentive Plan to increase the number of shares of common stock reserved for issuance thereunder by 1,000,000 (Proposal 2);
3.To ratify the appointment of Grant Thornton LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2021 (Proposal 3);
4.To approve, on an advisory basis, the compensation of our named executive officers (Proposal 4);
5.To transact such other business as may properly come before the Annual Meeting or any adjournments or postponements thereof.
|
| 2020-04-29 |
股东大会：
将于2020-06-18召开股东大会
会议内容 ▼▲
- 1.To elect three Class I directors (Proposal 1);
2.To ratify the appointment of Grant Thornton LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2020 (Proposal 2);
3.To approve, on an advisory basis, the compensation of our named executive officers (Proposal 3);
4.To transact such other business as may properly come before the Annual Meeting or any adjournments or postponements thereof.
|
| 2019-11-15 |
详情>>
拆分方案：
每15.0000合并分成1.0000股
|
| 2019-09-27 |
股东大会：
将于2019-11-04召开股东大会
会议内容 ▼▲
- 1.To approve a proposal to authorize our board of directors (the “Board”), in its sole and absolute discretion, and without further action of the stockholders, to file an amendment to our restated certificate of incorporation, as amended to the date of this proxy statement (the “Certificate of Incorporation”), to effect a reverse stock split of our issued and outstanding Common Stock, par value $0.01 per share (“common stock”) at a ratio to be determined by the Board, ranging from one-for-five to one-for-30 (the “Reverse Split”), with the Reverse Split to be effected at such time and date, if at all, as determined by the Board in its sole discretion, but no later than May 4, 2020, when the authority granted in this proposal to implement the Reverse Split would terminate (Proposal 1);
2.To approve an adjournment of the Special Meeting, if necessary and appropriate, as determined by the Board in its sole discretion, to solicit additional proxies if there are insufficient votes at the time of the Special Meeting to approve Proposal 1 or to constitute a quorum (Proposal 2).
|
| 2019-04-29 |
股东大会：
将于2019-06-18召开股东大会
会议内容 ▼▲
- 1. To elect two Class III directors (Proposal 1);
2. To ratify the appointment of Grant Thornton LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2019 (Proposal 2);
3. To approve, on an advisory basis, the compensation of our named executive officers (Proposal 3);
4. To approve the Alimera Sciences, Inc. 2019 Omnibus Incentive Plan (Proposal 4);
5. To transact such other business as may properly come before the Annual Meeting or any adjournments or postponements thereof.
|
| 2018-04-30 |
股东大会：
将于2018-06-19召开股东大会
会议内容 ▼▲
- 1.To elect one Class II director (Proposal 1);
2.To ratify the appointment of Grant Thornton LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2018 (Proposal 2);
3.To approve, on an advisory basis, the compensation of our named executive officers (Proposal 3);
4.To transact such other business as may properly come before the Annual Meeting or any adjournments or postponements thereof.
|
| 2017-04-26 |
股东大会：
将于2017-06-22召开股东大会
会议内容 ▼▲
- 1. To elect three Class I directors ;
2. To ratify the appointment of Grant Thornton LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2017;
3. To approve, on an advisory basis, the compensation of our named executive officers ;
4. To transact such other business as may properly come before the annual meeting or any adjournments or postponements thereof.
|
| 2016-10-14 |
股东大会：
将于2016-11-16召开股东大会
会议内容 ▼▲
- 1. To approve an amendment to the Company’s Restated Certificate of Incorporation to increase the number of authorized shares of common stock, par value $0.01 per share, from 100,000,000 shares to 150,000,000 shares;
2. To transact such other business as may properly come before the Special Meeting or any adjournment or postponement thereof.
|
| 2016-04-27 |
股东大会：
将于2016-06-23召开股东大会
会议内容 ▼▲
- 1. To elect three Class III directors;
2. To ratify the appointment of Grant Thornton LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2016;
3. To approve, on an advisory basis, the compensation of our named executive officers;
4. To transact such other business as may properly come before the annual meeting or any adjournments or postponements thereof.
|
| 2015-04-30 |
股东大会：
将于2015-06-25召开股东大会
会议内容 ▼▲
- 1. To elect two Class II directors (Proposal 1);
2. To ratify the appointment of Grant Thornton LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2015 (Proposal 2);
3. To approve, on an advisory basis, the compensation of our named executive officers (Proposal 3);
4. To transact such other business as may properly come before the annual meeting or any adjournments or postponements thereof.
|